PRI-2191, PRI-1907 and PRI-1917 downregulated the expression of NANOG, OCT3/4 and SOX2, i.e., pluripotent stem cell-related genes involved in the stem cell renewal, which are aberrantly overexpressed in several cancers [35,36]. The gene discussed is SOX2; the disease is cancer.